Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Lilly expands pain pipeline via US$ 1 bn SiteOne buyout; US cancels funding for Moderna's bird flu vaccine

In news this week, Eli Lilly has placed a billion-dollar bet on non-opioid pain management by acquiring SiteOne Therapeutics fo...

Impressions : 518

Pfizer inks US$ 6 bn oncology deal with China's 3SBio; BioNTech to invest US$ 1.3 bn in UK for new R&D, AI centers

In news this week, Pfizer announced a US$ 6 billion licensing agreement with China’s 3SBio, securing global rights to a p...

Impressions : 574

Trump signs 'most favored nation' executive order to slash drug costs; Sanofi, Takeda pledge mega investments in US

The US President Donald Trump’s dramatic intervention in pharmaceutical pricing took centerstage as the White House unvei...

Impressions : 679

BMS to invest US$ 40 bn to boost US manufacturing, R&D; 19 states sue Trump admin for gutting health agencies

US President Donald Trump’s tariff threats appear to be working, as Bristol Myers Squibb became the latest drugmaker to a...

Impressions : 1594

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Lilly expands pain pipeline via US$ 1 bn SiteOne buyout; US cancels funding for Moderna's bird flu vaccine

Pfizer inks US$ 6 bn oncology deal with China's 3SBio; BioNTech to invest US$ 1.3 bn in UK for new R&D, AI centers

Trump signs 'most favored nation' executive order to slash drug costs; Sanofi, Takeda pledge mega investments in US

BMS to invest US$ 40 bn to boost US manufacturing, R&D; 19 states sue Trump admin for gutting health agencies

Avit's Generics Sitagliptin Receives Approval in US

Dr Reddy's Generics Sitagliptin Receives Approval in US

MSN's Generics Sacubitril Receives Tentative Approval in US

Boehringer 's Biologics Spevigo Receives Suppl Approval in US

BMS's Biologics Yervoy Receives Suppl Approval in US

BMS's Biologics Opdivo Receives Suppl Approval in US

BMS's Biologics Opdivo Qvantig Receives Suppl Approval in US

Merck's Biologics Keytruda Receives Suppl Approval in US

Celltrion's Biologics Herzuma Receives Suppl Approval in US

Eli Lilly's Biologics Ebglyss Receives Suppl Approval in US

Enforcement Report - Week of June 4, 2025

Zhejiang Easyclean Daily Chemical Recieves Warning Letter

Evi Labs Recieves Warning Letter

Yiling Pharmaceutical Recieves Warning Letter

CTK OTC Laboratories Recieves Warning Letter

Rechon Life Science Recieves Warning Letter

Enforcement Report - Week of May 28, 2025

Everlaan Organics is on FDA Import Alert List

GSK's Biologics Nucala Receives Suppl Approval in US

Umary Issues a Nationwide Recall of Unavy Acidio Hialuronico

Enforcement Report - Week of June 4, 2025

Bayer to Share New Data from KERENDIA Trial at Renal Congress

Fujirebio launches Lumipulse G sTREM2 Assay for Research

Merus N.V. Announces Pricing of Public Offering of Common Shares

Moderna to Conduct True Placebo Trial for New Covid Vaccine

Roche & Jazz Link Drug Combo to Improve Survival in Ph 3 Trial

Indoco Launches Ticagrelor Tablets 90mg in UK Market

Sun Pharma Stops SCD-044 Drug Development Due to Trial Results

Zydus Partners with Agenus for Cancer Therapies in India

Merck made $3B offer for MoonLake & could revive interest

AVEO Oncology, LG Chem Present Three Posters at ASCO 2025 Meeting

Avenacy Launches Leuprolide Acetate Injection in U.S. Market

Biocon Gets Approval for Diabetes Drug Liraglutide in India

Zydus gets USFDA nod for Generic IBS-D treatment drug

Meitheal Pharmaceuticals Launches Generic Paclitaxel in US

Nexus Wins Patent Litigation for Injectable Cyclophosphamide

Supernus Announces Paragraph IV ANDA Filings for Qelbree

Avenacy Launches Doxycycline for Injection in U.S. Market

Axsome Therapeutics Settles Sunosi Patent Dispute with Hetero Lab

Apotex Launches Generic Tasigna Capsules in Us with Exclusivity

Moderna to Conduct True Placebo Trial for New Covid Vaccine

Roche & Jazz Link Drug Combo to Improve Survival in Ph 3 Trial

Zydus Partners with Agenus for Cancer Therapies in India

Merck made $3B offer for MoonLake & could revive interest

Transpire licenses PDE4 inhibitor for lung disease

BioAge inks Option Agreement for Chinese biotech's Obesity Asset

Haya Therapeutics Moves San Diego Operations to Lilly Gateway Lab

Orbis Boosts Oral Macrocycle Platform With Gefion AI

Leyden Labs secures €20M EIB Investment for Pandemic Preparedness

MarkHerz, TUM Hospital sign MOU for Cardiovascular and Diabetes

Lonza Launches Design2Optimize for Small Molecule API Development

Lilly weighs Houston as option for new $5.9B API facility

Skyepharma Expands Oncology Operational Facility in France

Zydus receives EIR for the Ambernath API manufacturing facility

Benuvia Operations Signs Supply Deal for Dronabinol API

IGC Pharma Presents Genetic Toxicology Data at 2025 Meeting

Sigachi Industries Gets Cep for Metformin Hydrochloride from Edqm

SMS Pharmaceuticals Vizag plant gets WHO Geneva prequalification

API China 2025: Explore Chenghuis GMP-Certified Portfolio

Efficient project management in pharma: 8 steps to optimize

US FDA's Surprise Foreign Inspections Plan Impact on India

Piramal Pharma completes USFDA inspection of Aurora facility

Pharmala Biotech Warns Against Fake Products Claiming to Be Their

Gene editing leaders call for 10-year ban on heritable edits

US Appeals Court Rejects Challenge to Federal Marijuana Ban

Dr Reddy's gets 2 observations from USFDA for Telangana API plant

FDA Warns About GMP Violations, False Drug Advertising

Alpha Genesis Passes USDA Inspection, Advances Health Mission

Symbiosis completes MHRA audit of new Fill/Finish Facility

Dr Reddy's gets 2 observations from USFDA for New York API plant

Fujirebio launches Lumipulse G sTREM2 Assay for Research

FDA Grants Breakthrough Designation to Guardant Health's MCD Test

Prostate Cancer Foundation Starts 30th Annual Home Run Challenge